Abstract
Sleepless in America: Compounding with Melatonin
Author(s): Wynn Tom, Rawlings Kate
Issue: Jan/Feb 2010 - Pediatrics and Wellness
Page(s): 10-13
Abstract
Studies of melatonin in the 1970s and 1980s revealed sedative and hypnotic properties of the compound, which have lead to its use in treating sleep disorders. Commonly used for jet lag, melatonin is relatively inexpensive and associated with minimal side effects. Regulation of melatonin secretion appears to be abnormal in children and adults in which pervasive development disorders have been observed. Alteration in melatonin rhythm may be responsible for sleep-onset and maintenance difficulties in autism. A recent review concluded that melatonin primarily acts on the total length of time needed to fall asleep and on the total length of sleep. In addition, melatonin, which does not induce dependence or withdrawal syndromes, may have advantages compared to commonly prescribed benzodiazepines. While there is an enormous amount of anecdotal information available, additional studies are necessary involving melatonin for the treatment of sleep disorders. The conditions of these well-controlled studies must be clear
Related Keywords
Related Categories
Related Articles from IJPC
| Issue/Page View/Buy |
Title/Author (Click for Abstract / Details / Purchase) |
|---|---|
|
Jan/Feb 2010
Pg. 10-13
|
|
|
Jan/Feb 2022
Pg. 6-8
|
|
|
Nov/Dec 2016
Pg. 512
|
|
|
Jan/Feb 2022
Pg. 18-23
|
|
|
May/Jun 2011
Pg. 246
|
|
|
Sep/Oct 2009
Pg. 386-389
|
|
|
Jan/Feb 2009
Pg. 6-12
|
|
|
Jan/Feb 2020
Pg. 62
|
|
|
May/Jun 2004
Pg. 181-185
|
|
|
Jul/Aug 2009
Pg. 296-299
|
|
|
Jan/Feb 2004
Pg. 46-48
|
|
|
Jan/Feb 2001
Pg. 18-19
|
|
|
Jan/Feb 2007
Pg. 27
|
|
|
May/Jun 2017
Pg. 205-211
|
|
|
Jul/Aug 2018
Pg. 270-278
|
|
|
Nov/Dec 2022
Pg. 468-472
|
|
|
May/Jun 2010
Pg. 182-192
|
|
|
Jan/Feb 2011
Pg. 27-31
|
|
|
Nov/Dec 2008
Pg. 498-504
|
|
|
Nov/Dec 2005
Pg. 413-420
|